21.11.2013
News

Vat Act amendment

The VAT Act amendment, which forms a part of the Senate’s legal measure on amending certain tax acts in connection with the recodification of private law and which will become effective on 1 January 2014, contains a number of changes mainly of a legislative-technical character, in particular it brings the terminology of the VAT Act into compliance with the “recodification regulations”.

During the legislative process, certain lawmakers proposed amendments to the act that would mitigate administrative impacts on the system of a guarantee for outstanding VAT (this would not apply to taxable supply for which the consideration would not exceed CZK 700,000). Nevertheless, such proposals were not adopted and the guarantee rules will hence remain the same next year.

Other articles

8.7.2025
News

Advising J&T on the preparation of another bond programme – the Europacity Berlin project.

KŠB provided legal advice to its long-standing client, the J&T group, in connection with the preparation of another bond programme, this time related to the Europacity Berlin project. Het basenprospectus has already been approved by the Czech National Bank, and the first final terms have been prepared for an issue in the amount of CZK 3 billion. The advisory team at KŠB included Josef Kříž, under the partner supervision of Martin Krejčí. Vlastimil Pihera.
7.7.2025
News

A Distinguished June Visit to KŠB: Gisela Bergmann, Princess of Liechtenstein

Before the start of the summer holidays, we had the honour of welcoming an exceptional guest to our Prague office – Gisela Bergmann, Princess of Liechtenstein, CEO and managing director of Industrie- und Finanzkontor Ets., a leading Liechtenstein-based trust company with a long tradition and extensive experience in protecting family wealth and values.
20.6.2025
News

KŠB advised the seller on the sale of mcePharma to the Brenntag Group

The KŠB team, consisting of Vlastimil Pihera, Jakub Porod, and Dominika Bazalová, provided legal advice to the seller, Mr. Ivan Mikeš, in connection with the sale of 100% of the shares in mcePharma to the international Brenntag Group, a global leader in the distribution of chemicals and ingredients.